Ocean Biomedical, Inc. (NASDAQ:OCEAW) Short Interest Down 18.9% in April

Ocean Biomedical, Inc. (NASDAQ:OCEAW) was the target of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 4,300 shares, a decrease of 18.9% from the March 31st total of 5,300 shares. Based on an average trading volume of 57,600 shares, the short-interest ratio is currently 0.1 days.

Ocean Biomedical Stock Performance

NASDAQ:OCEAW traded up $0.02 on Monday, reaching $0.10. 5,697 shares of the stock traded hands, compared to its average volume of 52,860. Ocean Biomedical has a 1-year low of $0.02 and a 1-year high of $0.70. The company’s 50 day moving average is $0.22 and its 200-day moving average is $0.11.

Ocean Biomedical Company Profile

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.